There could be a shortage of personal protective equipment, such as masks, in health care settings due to the novel coronavirus (2019-nCoV) outbreak, the World Health Organization, Centers for Disease Control and Prevention, and Department of Health and Human Services reiterated today. 
 
“Demand is up to 100 times higher than normal, and prices are up to 20 times higher,” said WHO Director-General Tedros Adhanom Ghebreyesus. “This situation has been exacerbated by widespread, inappropriate use of PPE outside patient care.”
 
WHO said the Pandemic Supply Chain Network will encourage manufacturers to increase production, commit supplies to frontline health emergency responders, and expand the number of stakeholders who are involved in the PSCN to gain a critical mass of suppliers to mitigate the operational risks within the market.
 
In a briefing today, members of President Trump’s Novel Coronavirus Task Force said more than 17,000 passengers returning from China have been screened at U.S. airports. 

HHS and CDC today issued an interim final rule requiring airlines to collect and provide to CDC certain data regarding passengers and crew arriving from foreign countries “for the purposes of health education, treatment, prophylaxis, or other appropriate public health interventions, including travel restrictions.”

Nancy Messonnier, M.D., director of CDC’s National Center for Immunization and Respiratory Diseases, said the nation’s “strong public health system” will be able to detect and respond to new U.S. cases, and that all 50 states plus Washington, D.C., and Guam should receive 2019-nCoV Real-Time RT-PCR Diagnostic Panel test kits today or tomorrow.
 
CDC will host a series of calls with state and local partners starting Monday, Feb. 10, at 2 p.m. ET. To participate, call 1-800-857-6697, passcode 1324420. For the latest information and resources, visit AHA's coronavirus webpage.

Related News Articles

Headline
The Centers for Disease Control and Prevention Sept. 24 released its annual report on national sexually transmitted disease data, reporting a 9% decline in STD…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The flu hospitalization rate during the 2024-25 flu season was the highest since 2010-11, according to a report published Sept. 12 by the Centers for Disease…